Aerosol delivery of chemotherapy in an orthotopic model of lung cancer

F. Gagnadoux, A. Le Pape, E. Lemarié, S. Lerondel, I. Valo, V. Leblond, J. L. Racineux, T. Urban (Angers, Orléans, Tours, France)

Source: Annual Congress 2005 - Chemotherapy and palliative care
Session: Chemotherapy and palliative care
Session type: Oral Presentation
Number: 195
Disease area: Thoracic oncology

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Gagnadoux, A. Le Pape, E. Lemarié, S. Lerondel, I. Valo, V. Leblond, J. L. Racineux, T. Urban (Angers, Orléans, Tours, France). Aerosol delivery of chemotherapy in an orthotopic model of lung cancer. Eur Respir J 2005; 26: Suppl. 49, 195

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Aerosol delivery of chemotherapy in an orthotopic model of lung cancer
Source: Eur Respir J 2005; 26: 657-661
Year: 2005



Is there any place for perioperative radiation therapy?
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005

Chemotherapy for small cell lung cancer
Source: Annual Congress 2006 - PG12 - Small cell lung cancer management
Year: 2006


Optimal integration of chemo- and radiotherapy in small cell lung cancer
Source: Annual Congress 2006 - PG12 - Small cell lung cancer management
Year: 2006


Role of chemotherapy in stage III non-small cell lung cancer (NSCLC): adjuvant or induction?
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Chemotherapy in nonsmall cell lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=218
Year: 2001

Lung function evaluation in gemcitabine and concurrent radiotherapy treatment in nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2001; 18: Suppl. 33, 376s
Year: 2001

Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer
Source: Eur Respir J 2006; 27: 1183-1189
Year: 2006



Neoadjuvant and adjuvant treatment for operable nonsmall cell lung cancer
Source: Eur Respir Mon; 2009: 44: 244–259
Year: 2009

Carboplatin and paclitaxel chemotherapy for lung cancer patients with interstitial lung disease
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010

Radiotherapy of nonsmall and small cell lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=190
Year: 2001

Treatment of advanced non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005


Cost-utility analysis of chemotherapy in symptomatic advanced nonsmall cell lung cancer
Source: Eur Respir J 2006; 27: 895-901
Year: 2006



Implementation study: role of docetaxel after a first line cisplatinum based chemotherapy for non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2004; 24: Suppl. 48, 303s
Year: 2004

Adjuvant therapy in NSCLC
Source: Annual Congress 2007 - Clinical year in review
Year: 2007


Chemotherapy in advanced nonsmall cell lung cancer
Source: Eur Respir Mon; 2009: 44: 271–283
Year: 2009

A phase I study of aerosolized gemcitabine in non-small-cell lung cancer
Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology
Year: 2007


Treatment of limited disease-small cell lung cancer
Source: Eur Respir Mon; 2009: 44: 299–309
Year: 2009

Neo-adjuvant chemotherapy: level of evidence in early stage and in marginally resectable disease
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005

Phase I/II study of biweekly docetaxel/cisplatin with concurrent thoracic radiotherapy for locally advanced non-small cell lung cancer
Source: Annual Congress 2005 - Chemotherapy and palliative care
Year: 2005